2/25/2010

The FDA approved Pfizer's Prevnar 13 pneumococcal vaccine for children ages 6 weeks to 5 years. The product targets 13 strains of Streptococcus pneumoniae, including the 19A strain that was not in the original Prevnar.

Related Summaries